Robert Barrow, CEO: Definium Therapeutics DFTX Buy · Filed 24/08/20

Trade details

Type: Insider buy
Amount: $3,155
Shares · price: 500 sh · $6.31 a share
Held after: 565,043 sh
Stock: Definium Therapeutics DFTX
Person: Robert BarrowCEO
Trade date: 24/08/19
Filed: 24/08/20
Days to filing: 1 days

First buy since 2023

Insiders buying this week: 2 insiders
Holding change: +0.1%

Definium Therapeutics trades, last 26 weeks

What else happened in Definium Therapeutics around then

Filed or reported within 30 days of the trade day · 24/07/20~24/09/18

Robert Barrow's recent trades

Robert BarrowCEO
Sell10b5-1 planDefinium Therapeutics
Sell10b5-1 plan
Definium Therapeutics
DFTX
$1.2M
31,550 sh
$1.2M
Filed 09/29
Traded 09/25
Robert BarrowCEO
Planned saleDefinium Therapeutics
Planned sale
Definium Therapeutics
DFTX
$1.2M
31,550 sh
$1.2M
Filed 09/25
Traded 09/25
Robert BarrowCEO
Planned saleDefinium Therapeutics
Planned sale
Definium Therapeutics
DFTX
$718.1K
19,023 sh
$718.1K
Filed 09/03
Traded 09/03
Robert BarrowCEO
Sell10b5-1 planDefinium Therapeutics
Sell10b5-1 plan
Definium Therapeutics
DFTX
$1.3M
29,208 sh
$1.3M
Filed 06/26
Traded 06/25
Robert BarrowCEO
Planned saleDefinium Therapeutics
Planned sale
Definium Therapeutics
DFTX
$1.2M
29,208 sh
$1.2M
Filed 06/25
Traded 06/25

Robert Barrow, CEO — bought $3,155 of Definium Therapeutics DFTX · 500 sh @ $6.31 | Whalegun